share

[Phe1-Psi(Ch2-Nh)Gly2]Nociceptin(1-13)Nh2 CAS NO 213130-17-7


Unit Price:

CAS No.:213130-17-7

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

[Phe1-Psi(Ch2-Nh)Gly2]Nociceptin(1-13)NH2 is a synthetic, pseudopeptide analog of the endogenous neuropeptide nociceptin/orphanin FQ (N/OFQ). This compound is specifically engineered with a reduced peptide bond (psi) to enhance metabolic stability and receptor selectivity, making it a critical tool for advanced neuroscience and pharmacological research. It is primarily utilized by research institutions and pharmaceutical R&D departments focused on studying the NOP (nociceptin opioid peptide) receptor system, pain modulation, anxiety, and addiction pathways.

Application

  • Neuroscience Research: A key ligand for investigating the structure, function, and signaling pathways of the NOP (ORL-1) receptor.
  • Pharmacological Studies: Used in in vitro and in vivo assays to study nociceptin's role in pain perception, analgesia, and tolerance development.
  • Drug Discovery & Development: Serves as a reference standard and lead compound for developing novel therapeutics targeting pain, anxiety, depression, and substance use disorders.
  • Biochemical Assays: Employed in receptor binding studies, functional cAMP assays, and GTPγS binding experiments to characterize agonist/antagonist activity.
  • Metabolic Stability Research: The pseudopeptide modification makes it a model compound for studying peptide stability and bioavailability.

Basic Information

Product Name [Phe1-Psi(Ch2-Nh)Gly2]Nociceptin(1-13)NH2
CAS No. 213130-17-7
Molecular Formula C75H111N21O16
Molecular Weight 1550.83 g/mol
Synonyms [Phe¹ψ(CH₂NH)Gly²]Nociceptin(1-13)NH₂; Nociceptin (1-13), [Phe¹ψ(CH₂NH)Gly²]-; Pseudonociceptin(1-13)amide; (Phe¹-ψ(CH₂-NH)-Gly²)-Nociceptin(1-13)-NH₂; N/OFQ(1-13) analog, reduced bond; ORL-1 receptor agonist analog; Nociceptin pseudopeptide; F/G Nociceptin Fragment (1-13) analog
EINECS Contact for details

Quality Control

Our [Phe1-Psi(Ch2-Nh)Gly2]Nociceptin(1-13)NH2 is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, mass spectrometry for identity confirmation, and amino acid analysis. We provide a detailed Certificate of Analysis (COA) with every shipment, ensuring traceability and compliance with research-grade standards. Our quality commitment supports reproducible and reliable scientific outcomes.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below in a dry environment. This product is hygroscopic (moisture-sensitive). For long-term storage, consider desiccant and under an inert atmosphere. Allow the vial to equilibrate to room temperature before opening to minimize moisture condensation.

Specification

Item Specification
Appearance White to off-white lyophilized powder
Identification (HPLC) Retention time corresponds to reference standard
Identification (MS) Consistent with theoretical molecular weight
Purity (HPLC) ≥ 95%
Peptide Content ≥ 80% (by amino acid analysis)
Water Content (KF) ≤ 5.0%
Solubility Soluble in water, acetic acid, DMSO

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.